Portola Pharma (PTLA) Tops Q4 EPS by 8c

Portola Pharma (NASDAQ: PTLA) reported Q4 EPS of ($0.82), $0.08 better than the analyst estimate of ($0.90). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $2.73 million.

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Union Pacific (UNP) Tops Q1 EPS by 18c
• Tractor Supply (TSCO) Tops Q1 EPS by 12c ; Offers Guidance
• CEMEX, S.A.B. de C.V. (CX) Tops Q1 EPS by 5c